Cite
HARVARD Citation
Jakobsen, A. et al. (2022). TDP1 and TOP1 as targets in anticancer treatment of NSCLC: Activity and protein level in normal and tumor tissue from 150 NSCLC patients correlated to clinical data. Lung cancer. pp. 23-32. [Online].